Cases and Conversations™: Navigating the New Immunotherapy Era in Squamous Cell Anal Carcinoma
Share
Subscribe
Highlights from the PER® CME activity "Cases and Conversations™: Navigating the New Immunotherapy Era in Squamous Cell Anal Carcinoma" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.
In this podcast, experts Marwan Fakih, MD, Kristen Ciombor, MD, MSCI, and Van Karlyle Morris, MD, discuss the treatment of advanced squamous cell anal carcinoma in the immunotherapy era, with a focus on epidemiology, frontline treatment, and novel approaches to immunotherapy-refractory disease.
Earn CME credit by completing the full accredited activity (available through February 27, 2027):
https://www.gotoper.com/cc26squamous-activity
This podcast, including the narration, was developed by PER® (Physicians’ Education Resource®, LLC) editorial staff from the full online CME activity developed with these faculty. The narration was voiced by a PER staff member or by an AI tool. The podcast contains no product advertising. The full activity is supported by an educational grant from Incyte Corporation.
This content is for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Faculty may discuss investigational or off-label uses; consult prescribing information for any products discussed.